Johnsson M, Farman HH, Blennow K, Zetterberg H, et al. No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab. Mult Scler 2022 Jul 20:13524585221108080. doi: 10.1177/13524585221108080.
PMID: 35856574